blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0634169

EP0634169 - Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis [Right-click to bookmark this link]
Former [1995/03]Pharmaceutical composition containing quinoline or quinazoline derivatives
[1999/13]
StatusNo opposition filed within time limit
Status updated on  03.11.2000
Database last updated on 10.05.2025
Most recent event   Tooltip28.12.2007Lapse of the patent in a contracting state
New state(s): IT
published on 30.01.2008  [2008/05]
Applicant(s)For all designated states
Takeda Chemical Industries, Ltd.
1-1, Doshomachi, 4-chome Chuo-ku
Osaka 541 / JP
[N/P]
Former [1995/03]For all designated states
TAKEDA CHEMICAL INDUSTRIES, LTD.
1-1, Doshomachi 4-chome
Chuo-ku, Osaka 541 / JP
Inventor(s)01 / Sohda, Takashi
27-20, Higashikanmaki 2-chome
Osaka 569 / JP
02 / Taketomi, Shigehisa
11-11, Hachizuka 3-chome
Ikeda, Osaka 563 / JP
03 / Baba, Atsuo
10-32-302, Hama-ashiyacho
Ashiya, Hyogo 659 / JP
[1995/03]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [1995/03]von Kreisler, Alek, Dipl.-Chem., et al
Patentanwälte, von Kreisler-Selting-Werner, Bahnhofsvorplatz 1 (Deichmannhaus)
D-50667 Köln / DE
Application number, filing date94109861.825.06.1994
[1995/03]
Priority number, dateJP1993015865229.06.1993         Original published format: JP 15865293
[1995/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0634169
Date:18.01.1995
Language:EN
[1995/03]
Type: B1 Patent specification 
No.:EP0634169
Date:05.01.2000
Language:EN
[2000/01]
Search report(s)(Supplementary) European search report - dispatched on:EP14.11.1994
ClassificationIPC:A61K31/395, A61K31/495, A61K31/47, A61K31/435, A61K31/505
[1995/03]
CPC:
C07D231/12 (EP,US); A61K31/47 (EP,US); A61K31/4709 (EP,US);
A61K31/4741 (EP,US); A61K31/4745 (EP,US); A61K31/50 (EP,US);
A61K31/505 (EP,US); A61K31/517 (EP,US); C07D215/54 (EP,US);
C07D233/56 (EP,US); C07D249/08 (EP,US); C07D401/12 (EP,US);
C07D403/12 (EP,US); C07D417/12 (EP,US); C07D491/04 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1995/03]
TitleGerman:Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose[1999/13]
English:Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis[2000/01]
French:Dérivés quinolines ou quinazolines et leur utilisation dans la fabrication d'un médicament pour le traitement de l'ostéoporose[2000/01]
Former [1995/03]Pharmazeutische Zusammensetzung enthaltend Chinoline oder Chinazolin-Derivate
Former [1995/03]Pharmaceutical composition containing quinoline or quinazoline derivatives
Former [1995/03]Composition pharmaceutique contenant des dérivés quinalines ou quinozolines
Examination procedure14.07.1995Examination requested  [1995/36]
03.04.1996Despatch of a communication from the examining division (Time limit: M06)
01.10.1996Reply to a communication from the examining division
04.11.1996Despatch of a communication from the examining division (Time limit: M06)
05.03.1997Reply to a communication from the examining division
09.06.1997Despatch of a communication from the examining division (Time limit: M02)
10.06.1997Reply to a communication from the examining division
04.03.1999Despatch of communication of intention to grant (Approval: Yes)
08.07.1999Communication of intention to grant the patent
10.09.1999Fee for grant paid
10.09.1999Fee for publishing/printing paid
Opposition(s)06.10.2000No opposition filed within time limit [2000/51]
Fees paidRenewal fee
26.06.1996Renewal fee patent year 03
27.06.1997Renewal fee patent year 04
27.06.1998Renewal fee patent year 05
29.06.1999Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.01.2000
BE05.01.2000
ES05.01.2000
GR05.01.2000
IT05.01.2000
NL05.01.2000
SE05.01.2000
DK05.04.2000
PT05.04.2000
LU25.06.2000
IE26.06.2000
[2008/05]
Former [2004/39]AT05.01.2000
BE05.01.2000
ES05.01.2000
GR05.01.2000
NL05.01.2000
SE05.01.2000
DK05.04.2000
PT05.04.2000
LU25.06.2000
IE26.06.2000
Former [2004/07]AT05.01.2000
BE05.01.2000
ES05.01.2000
GR05.01.2000
NL05.01.2000
SE05.01.2000
DK05.04.2000
PT05.04.2000
IE26.06.2000
Former [2003/45]AT05.01.2000
BE05.01.2000
ES05.01.2000
NL05.01.2000
SE05.01.2000
DK05.04.2000
PT05.04.2000
IE26.06.2000
Former [2003/08]AT05.01.2000
BE05.01.2000
ES05.01.2000
NL05.01.2000
SE05.01.2000
PT05.04.2000
IE26.06.2000
Former [2002/26]AT05.01.2000
BE05.01.2000
ES05.01.2000
SE05.01.2000
PT05.04.2000
IE26.06.2000
Former [2002/23]AT05.01.2000
BE05.01.2000
SE05.01.2000
PT05.04.2000
IE26.06.2000
Former [2001/50]AT05.01.2000
BE05.01.2000
PT05.04.2000
IE26.06.2000
Former [2001/09]AT05.01.2000
BE05.01.2000
PT05.04.2000
Former [2001/08]AT05.01.2000
BE05.01.2000
Documents cited:Search[X]US4343940  (KREIGHBAUM WILLIAM E, et al) [X] 1,2,26 * "compound 15"; columns 7-8; table 1 *;
 [A]EP0403185  (ROBINS CO INC A H [US]) [A] 1-27* claim 1 *;
 [PX]EP0567107  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [PX] 1-19,21,22,24-26 * page 2, line 9 - line 26; claims 1,26; tables 9-21 *;
 [DE]EP0608870  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [DE] 1-3,7,8,10-26 * claims 1,18-20; tables 2-9 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.